Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $110

Wells Fargo analyst Wesley Carmichael has maintained an Overweight rating on MetLife (NYSE: MET) and increased the price target from $109 to $110. This adjustment reflects a positive outlook on the company's performance.